NCT02726971View on ClinicalTrials.gov

Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Asherman Syndrome
Interventions
DRUG

Femoston

Femoston is a Complex Packing Estradiol Tablets and Estradiol and Dydrogesterone.

Trial Locations (1)

100038

Fu Xing Hospital,Capital Medical University, Beijing

All Listed Sponsors
lead

Fu Xing Hospital, Capital Medical University

OTHER

NCT02726971 - Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion | Biotech Hunter | Biotech Hunter